TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration

被引:65
|
作者
Sephton, Chantelle F. [1 ]
Cenik, Basar [1 ,3 ]
Cenik, Bercin Kutluk [2 ]
Herz, Joachim [3 ]
Yu, Gang [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
amyotrophic lateral sclerosis (ALS); neural development; PTPB2; RIP-seq; RNA binding protein; TDP-43; AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; NUCLEAR FACTOR TDP-43; MESSENGER-RNA; TRANSGENIC MICE; MOTOR DEFICITS; CFTR EXON-9; IN-VIVO; ALS;
D O I
10.1515/hsz-2012-0115
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
From the earliest stages of embryogenesis and throughout life, transcriptional regulation is carefully orchestrated in order to generate, shape, and reshape the central nervous system (CNS). TAR DNA-binding protein 43 (TDP-43) is identified as a regulator of essential transcriptional events in the CNS. Evidence for its importance comes from the identification of TDP-43 protein aggregates and genetic mutations in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Efforts are being made to learn more about the biological function of TDP-43 and gain a better understanding of its role in neurodegeneration. TDP-43 RNA targets and protein interactions have now been identified, and in vivo evidence shows that TDP-43 is essential in CNS development and function. This review will highlight aspects of these findings.
引用
收藏
页码:589 / 594
页数:6
相关论文
共 50 条
  • [41] TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration
    Xie, Manling
    Liu, Yong U.
    Zhao, Shunyi
    Zhang, Lingxin
    Bosco, Dale B.
    Pang, Yuan-Ping
    Zhong, Jun
    Sheth, Udit
    Martens, Yuka A.
    Zhao, Na
    Liu, Chia-Chen
    Zhuang, Yongxian
    Wang, Liewei
    Dickson, Dennis W.
    Mattson, Mark P.
    Bu, Guojun
    Wu, Long-Jun
    NATURE NEUROSCIENCE, 2022, 25 (01) : 26 - +
  • [42] Finding a chaperone for TDP-43
    Ayala, Yuna M.
    Grese, Zachary R.
    NATURE CELL BIOLOGY, 2022, 24 (09) : 1328 - 1330
  • [43] Phase to Phase with TDP-43
    Sun, Yulong
    Chakrabartty, Avijit
    BIOCHEMISTRY, 2017, 56 (06) : 809 - 823
  • [44] TDP-43 in neurodegenerative disorders
    Cook, Casey
    Zhang, Yong-Jie
    Xu, Ya-Fei
    Dickson, Dennis W.
    Petrucelli, Leonard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (07) : 969 - 978
  • [45] TDP-43: Overview of the series
    Baralle, Francisco E.
    Buratti, Emanuele
    FEBS JOURNAL, 2011, 278 (19) : 3529 - 3529
  • [46] TDP-43 Models Coverage
    Dance, Amber
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (04) : 1403 - 1408
  • [47] TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration
    Fiesel, Fabienne C.
    Kahle, Philipp J.
    FEBS JOURNAL, 2011, 278 (19) : 3550 - 3568
  • [48] NEUROSCIENCE Unwrapping TDP-43
    不详
    SCIENCE, 2022, 376 (6592) : 473 - 473
  • [49] Multiple system atrophy is not a TDP-43 proteinopathy
    Geser, F.
    Malunda, J.
    Wenning, G. K.
    Lee, V. M. -Y.
    Trojanowksi, J. Q.
    MOVEMENT DISORDERS, 2009, 24 : S426 - S427
  • [50] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8